Advanced Biomed Inc Foreign Currency Transaction Gain (Loss), before Tax
Advanced Biomed Inc (ADVB) reported Foreign Currency Transaction Gain (Loss), before Tax of -$365.51 thousand for the 3-month period ending 2024-12-31, per its 10-Q filed 2025-04-15.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2025-04-15
- Advanced Biomed Inc foreign currency transaction gain (loss), before tax for the quarter ending 2024-12-31 was -$365.51K, a 175.10% decline year-over-year.
- Advanced Biomed Inc foreign currency transaction gain (loss), before tax for the quarter ending 2023-12-31 was $486.71K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month |
|---|---|---|
| 2024-12-31 | -$365.51K 10-Q · filed 2025-04-15 | -$113.42K 10-Q · filed 2025-04-15 |
| 2023-12-31 | $486.71K 10-Q · filed 2025-04-15 | $155.02K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |